InterAx Overview

  • Year Founded
  • 2014

Year Founded

  • Status
  • Private

  • Employees
  • 17

Employees

  • Latest Deal Type
  • Later Stage VC
  • (Cancelled)

  • Investors
  • 11

InterAx General Information

Description

Developer of a GPCR drug discovery platform designed to cover hit-generation and hit-to-lead for all GPCR targets including orphan GPCRs. The company's platform integrates high-throughput biochemical screening with artificial intelligence and cell signaling mathematical modeling, enabling the healthcare industry to identify and optimize drug candidates for a wide range of diseases.

Contact Information

Website
www.interaxbiotech.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Park Innovaare
  • 5234 Villigen
  • Switzerland
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Vertical(s)
Artificial Intelligence & Machine Learning, HealthTech, Life Sciences
Corporate Office
  • Park Innovaare
  • 5234 Villigen
  • Switzerland

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

InterAx Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
9. Later Stage VC 03-Oct-2023 Cancelled Generating Revenue
8. Later Stage VC 01-Nov-2022 Completed Generating Revenue
7. Grant 25-Nov-2019 Completed Generating Revenue
6. Seed Round 15-Jan-2019 Completed Generating Revenue
5. Seed Round 23-Dec-2016 Completed Startup
4. Grant 21-Oct-2016 Completed Startup
3. Accelerator/Incubator 01-Jan-2016 Completed Startup
2. Grant 01-Aug-2014 $167K Completed Startup
1. University Spin-Out Completed Startup
To view InterAx’s complete valuation and funding history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Request a free trial

InterAx Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of a GPCR drug discovery platform designed to cover hit-generation and hit-to-lead for all GPCR targets includ
Drug Discovery
Villigen, Switzerland
17 As of 2023

San Diego, CA
 

South San Francisco, CA
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

InterAx Competitors (71)

One of InterAx’s 71 competitors is Vividion Therapeutics, a Formerly VC-backed company based in San Diego, CA.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Vividion Therapeutics Formerly VC-backed San Diego, CA
IDEAYA Biosciences Formerly VC-backed South San Francisco, CA
Sitryx Venture Capital-Backed Oxford, United Kingdom
Monte Rosa Therapeutics Formerly VC-backed Boston, MA
Alzheon Venture Capital-Backed Framingham, MA
You’re viewing 5 of 71 competitors. Get the full list »

InterAx Patents

  • 9

    Total Documents Applications and Grants

  • Total Patents Families

  • 4

    Granted

  • 2

    Pending

  • Expiring in next 12 mo

InterAx Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
EP-4238970-A1 Modulators of ackr3 and uses thereof Inactive 03-Mar-2022
EP-4486739-A1 Modulators of ackr3 and uses thereof Pending 03-Mar-2022
EP-3878447-A1 Beta adrenergic receptor antagonists Inactive 11-Mar-2020
EP-3914916-A1 Beta-arrestin mutants Inactive 22-Jan-2019
US-20220106382-A1 Beta-arrestin mutants Pending 22-Jan-2019 C07K14/723
To view InterAx’s complete patent history, request access »

InterAx Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

InterAx Investors (11)

Investor Name Investor Type Holding Investor Since Participating Rounds
Convergence Partners (Switzerland) Venture Capital Minority
Plug and Play Tech Center Accelerator/Incubator Minority
European Innovation Council Venture Capital Minority
Horizon 2020 Government
Bernina BioInvest Venture Capital Minority
You’re viewing 5 of 11 investors. Get the full list »

Ready to get started?

Request a free trial

InterAx FAQs

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »